FDA approves AI device that helps spot skin cancer
Jan 18, 2024
Along with helping to spot melanoma, the most deadly form of skin cancer, the device can also assess moles for basal cell carcinoma and squamous cell carcinoma.
Liver cancer in top five causes of cancer deaths in 90 countries
Oct 13, 2022
The number of people in whom liver cancer is diagnosed is predicted to rise substantially by 2040.
Statin use does not change benefits of prostate cancer screening
Dec 08, 2021
Less of an increase was reported in detection of low-grade localized tumors in statin users versus nonusers.
Deaths from 5 diseases decline
By
Lois A. Bowers
Oct 28, 2015
Wellness efforts may be having an effect. Deaths from five of the six leading causes saw an overall decline in the United States between 1969 and 2013, according to a new analysis.
Integration of MRI screening beneficial for prostate cancer
Apr 05, 2024
A reduction was seen in the odds of biopsy and insignificant prostate cancer, with no change in detection of clinically significant prostate cancer.
Life expectancy decreasing, CDC says
By
Lois A. Bowers
Aug 15, 2018
Life expectancy in the United States decreased in both 2015 and 2016, marking the only decreases in the past 20 years and the first consecutive two-year decline since 1964, according to a new report from...
Legalization of medical marijuana beneficial for cancer patients
Dec 05, 2022
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Weight loss in adulthood tied to reduced risk of colorectal adenoma
Feb 01, 2022
Weight loss from age 20 to age 55 to 74 years was linked to reduced risk, especially for those who were overweight or obese.
Cancer mortality rates increased for older seniors with T2DM
Feb 03, 2023
People with type 2 diabetes have increased colorectal, pancreatic, liver, and endometrial cancer mortality versus the general population.
Sugar-sweetened drink intake linked to mortality from some cancers
Sep 19, 2022
Sugar-sweetened beverages were associated with increased mortality for colorectal and kidney cancers, even after adjustment for body mass index.